NCT02973789 2026-03-18
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
NovoCure Ltd.
Phase 3 Completed
NovoCure Ltd.
University of Kentucky
Roswell Park Cancer Institute
ImmuneSensor Therapeutics Inc.
University of Pennsylvania
ImmuneSensor Therapeutics Inc.
SecuraBio
Fred Hutchinson Cancer Center